AbGn-168H
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AbGn-168H, covering 2013-11-01 to 2017-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant [Phase 1]